The transcription factor E2F: a crucial switch in the control of homeostasis and tumorigenesis.
暂无分享,去创建一个
[1] A. de Bruin,et al. Identification and Characterization of E2F7, a Novel Mammalian E2F Family Member Capable of Blocking Cellular Proliferation* , 2003, Journal of Biological Chemistry.
[2] Y. Wan,et al. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[3] J. Nevins,et al. Identification of a Novel E2F3 Product Suggests a Mechanism for Determining Specificity of Repression by Rb Proteins , 2000, Molecular and Cellular Biology.
[4] Joseph R. Nevins,et al. Identification of E-Box Factor TFE3 as a Functional Partner for the E2F3 Transcription Factor , 2003, Molecular and Cellular Biology.
[5] J. Nevins,et al. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function , 2002, The EMBO journal.
[6] M. Burghammer,et al. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] B. Pützer,et al. Role of the p53-homologue p73 in E2F1-induced apoptosis , 2000, Nature Genetics.
[8] H. Endo,et al. Apaf-1 Is a Mediator of E2F-1-induced Apoptosis* , 2002, The Journal of Biological Chemistry.
[9] J. Nevins,et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. , 2000, Molecular cell.
[10] Rosalind Eeles,et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome , 2004, Oncogene.
[11] Michael Q. Zhang,et al. Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters , 2001, Molecular and Cellular Biology.
[12] S. Gonzalo,et al. Linking the Rb and polycomb pathways. , 2001, Molecular cell.
[13] Matthew W. Strobeck,et al. BRG-1 is required for RB-mediated cell cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Tsai,et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. , 1998, Molecular cell.
[15] J. DeGregori,et al. Defective Gene Expression, S Phase Progression, and Maturation during Hematopoiesis in E2F1/E2F2 Mutant Mice , 2003, Molecular and Cellular Biology.
[16] J. Lloreta,et al. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. , 2004, The Journal of clinical investigation.
[17] J. Nevins,et al. Developmental control of a promoter-specific factor that is also regulated by the E1A gene product , 1987, Cell.
[18] M. Eilers,et al. Transcriptional repression by Myc. , 2003, Trends in cell biology.
[19] R. Spang,et al. Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis , 2001, Molecular and Cellular Biology.
[20] J. Nevins,et al. The E2F1–3 transcription factors are essential for cellular proliferation , 2001, Nature.
[21] D. Ginsberg,et al. Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis* , 2004, Journal of Biological Chemistry.
[22] J. Nevins,et al. Identification of a cellular transcription factor involved in E1A trans-activation , 1986, Cell.
[23] Yusuke Nakamura,et al. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain , 2004, Oncogene.
[24] D. Petereit,et al. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. , 2003, Cancer research.
[25] Young-Duck Kim,et al. E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide , 2003, Breast Cancer Research and Treatment.
[26] M. Greenberg,et al. E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.
[27] R. Bronson,et al. E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas , 2003, Molecular and Cellular Biology.
[28] Samuel L. Pfaff,et al. Analysis of embryonic motoneuron gene regulation: derepression of general activators function in concert with enhancer factors , 2004, Development.
[29] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[30] K. Moberg,et al. E2F activity is regulated by cell cycle-dependent changes in subcellular localization , 1997, Molecular and cellular biology.
[31] T. Volkert,et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.
[32] Seiichi Ishida,et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. , 2000, Molecular cell.
[33] H. A. Rogoff,et al. Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2 , 2004, Molecular and Cellular Biology.
[34] Duanduan Ma,et al. Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF , 2000, Cell.
[35] W. D. Cress,et al. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region , 2000, Oncogene.
[36] D. Ginsberg,et al. ATM is a target for positive regulation by E2F-1 , 2003, Oncogene.
[37] J. Nevins,et al. Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[38] Andrew J. Bannister,et al. An E2F-like repressor of transcription , 1997, Nature.
[39] David G Johnson,et al. E2F4 and E2F1 Have Similar Proliferative Properties but Different Apoptotic and Oncogenic Properties In Vivo , 2000, Molecular and Cellular Biology.
[40] P. Farnham,et al. Target Gene Specificity of E2F and Pocket Protein Family Members in Living Cells , 2000, Molecular and Cellular Biology.
[41] Stuart H. Orkin,et al. E2F1 and E2F2 Determine Thresholds for Antigen-Induced T-Cell Proliferation and Suppress Tumorigenesis , 2001, Molecular and Cellular Biology.
[42] R. Bronson,et al. Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In Vivo , 2002, Molecular and Cellular Biology.
[43] Michelle D. Garrett,et al. Cell cycle control and cancer. , 2001 .
[44] Ming Jiang,et al. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray. , 2004, International journal of molecular medicine.
[45] R. Bernards,et al. E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains , 2004, Oncogene.
[46] Rakesh Nagarajan,et al. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway , 2003, Oncogene.
[47] I. Lossos,et al. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene , 2005, Cell Death and Differentiation.
[48] A. Pająk,et al. Ca2+ and BMP-6 Signaling Regulate E2F during Epidermal Keratinocyte Differentiation* , 2001, The Journal of Biological Chemistry.
[49] R. Bernards,et al. Constitutive E2F1 Overexpression Delays Endochondral Bone Formation by Inhibiting Chondrocyte Differentiation , 2003, Molecular and Cellular Biology.
[50] K. Ryan,et al. Life and death decisions by E2F-1 , 2004, Cell Death and Differentiation.
[51] Jie-Oh Lee,et al. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 , 1998, Nature.
[52] J. Trimarchi,et al. E2f3 is critical for normal cellular proliferation. , 2000, Genes & development.
[53] Aaron Aslanian,et al. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. , 2004, Genes & development.
[54] Michael Ruogu Zhang,et al. Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. , 2001, Journal of molecular biology.
[55] G. Sauter,et al. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer , 2004, Oncogene.
[56] J. Nevins,et al. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. , 2001, Genes & development.
[57] R. Bronson,et al. E2F4 is essential for normal erythrocyte maturation and neonatal viability. , 2000, Molecular cell.
[58] David M. Livingston,et al. A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.
[59] M. Oren,et al. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F , 2005, Cell Death and Differentiation.
[60] K. Helin,et al. E2F target genes: unraveling the biology. , 2004, Trends in biochemical sciences.
[61] Kang Z. Liu,et al. A Role for 14-3-3τ in E2F1 Stabilization and DNA Damage-induced Apoptosis* , 2004, Journal of Biological Chemistry.
[62] Joseph B. Rayman,et al. E2F4 loss suppresses tumorigenesis in Rb mutant mice. , 2002, Cancer cell.
[63] K. Helin,et al. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription , 1998, Oncogene.
[64] Chung F. Wong,et al. E2F6: a member of the E2F family that does not modulate squamous differentiation. , 2004, Biochemical and biophysical research communications.
[65] I. Frazer,et al. E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes , 2000, Oncogene.
[66] Chung F. Wong,et al. E2F Modulates Keratinocyte Squamous Differentiation , 2003, Journal of Biological Chemistry.
[67] O. Hino,et al. Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. , 2004, Biochemical and biophysical research communications.
[68] D. Yap,et al. ASPP1 and ASPP2 are new transcriptional targets of E2F , 2005, Cell Death and Differentiation.
[69] C. Sardet,et al. A Novel Repressive E2F6 Complex Containing the Polycomb Group Protein, EPC1, That Interacts with EZH2 in a Proliferation-specific Manner* , 2005, Journal of Biological Chemistry.
[70] David I. Smith,et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis , 2000, Nature.
[71] Jeffrey M. Trimarchi,et al. Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.
[72] R. Halaban,et al. Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells , 2000, The Journal of experimental medicine.
[73] S. Kondo,et al. Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. , 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[74] D. Ginsberg,et al. Transcriptional regulation of AKT activation by E2F. , 2004, Molecular cell.
[75] T. Jacks,et al. Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1 , 1996, Cell.
[76] I. Screpanti,et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage , 2003, Nature Cell Biology.
[77] Tim Hui-Ming Huang,et al. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. , 2002, Genes & development.
[78] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[79] J. Fujimoto,et al. Expression of Cell-Cycle-Regulating Transcription Factor E2F-1 in Colorectal Carcinomas , 2000, Pathobiology.
[80] Peter L. Jones,et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.
[81] M. Varella‐Garcia,et al. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Harbour,et al. The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.
[83] Erez Y. Levanon,et al. Widespread occurrence of antisense transcription in the human genome , 2003, Nature Biotechnology.
[84] Steven P. Angus,et al. Retinoblastoma Tumor Suppressor: Analyses of Dynamic Behavior in Living Cells Reveal Multiple Modes of Regulation , 2003, Molecular and Cellular Biology.
[85] P. Hughes,et al. Cell differentiation and proliferation--simultaneous but independent? , 2003, Experimental cell research.
[86] D. Yap,et al. Novel Function of the Cyclin A Binding Site of E2F in Regulating p53-Induced Apoptosis in Response to DNA Damage , 2002, Molecular and Cellular Biology.
[87] J. Nevins,et al. E2Fs link the control of G1/S and G2/M transcription , 2004, The EMBO journal.
[88] Kang Z. Liu,et al. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. , 2004, Genes & development.
[89] J. Inazawa,et al. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. , 2003, Hepato-gastroenterology.
[90] W. Kaelin,et al. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation , 2000, Nature.
[91] J. Nevins,et al. Promoter interaction of the E1A‐inducible factor E2F and its potential role in the formation of a multi‐component complex. , 1987, The EMBO journal.
[92] Joseph B. Rayman,et al. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. , 2000, Genes & development.
[93] S. Field,et al. A role for E2F1 in the induction of apoptosis during thymic negative selection. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[94] John T. Powers,et al. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. , 2004, Molecular cancer research : MCR.
[95] Jeong Ho Chang,et al. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. , 2002, Genes & development.
[96] B. Spike,et al. New roles for the RB tumor suppressor protein. , 2004, Current opinion in genetics & development.
[97] R. K. Hyde,et al. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins. , 2002, Investigative ophthalmology & visual science.
[98] J. Trimarchi,et al. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[99] F. Dick,et al. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. , 2003, Molecular cell.
[100] Andrew J. Bannister,et al. Rb targets histone H3 methylation and HP1 to promoters , 2001, Nature.
[101] J. Trimarchi,et al. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[102] J. Auwerx,et al. E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.
[103] F. Christians,et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.
[104] Seiichi Mori,et al. A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. , 2004, Genes & development.
[105] N. Dyson,et al. A revised picture of the E2F transcriptional network and RB function. , 2002, Current opinion in cell biology.
[106] Hua,et al. Identification of , 2000, Journal of insect physiology.
[107] J. Nevins,et al. Combinatorial gene control involving E2F and E Box family members , 2004, The EMBO journal.
[108] A. de Bruin,et al. Cloning and Characterization of Mouse E2F8, a Novel Mammalian E2F Family Member Capable of Blocking Cellular Proliferation* , 2005, Journal of Biological Chemistry.
[109] Kristian Helin,et al. Identification of Target Genes of the p16INK4A-pRB-E2F Pathway* , 2003, Journal of Biological Chemistry.
[110] D. Monté,et al. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells , 2003, British Journal of Cancer.
[111] T. Jacks,et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice , 1998, Nature Genetics.
[112] J. Bartek,et al. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization , 1997, Molecular and cellular biology.
[113] K. Helin,et al. E2F7, a novel E2F featuring DP‐independent repression of a subset of E2F‐regulated genes , 2003, The EMBO journal.
[114] A. Caron,et al. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. , 2001, Genes & development.
[115] Karen H. Vousden,et al. p14ARF links the tumour suppressors RB and p53 , 1998, Nature.
[116] N. Dyson. The regulation of E2F by pRB-family proteins. , 1998, Genes & development.
[117] M. Emi,et al. Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers , 2004, Journal of Human Genetics.
[118] David S. Park,et al. The Proapoptotic Gene SIVA Is a Direct Transcriptional Target for the Tumor Suppressors p53 and E2F1* , 2004, Journal of Biological Chemistry.
[119] J. Bonventre,et al. TRIP-Br Links E2F to Novel Functions in the Regulation of Cyclin E Expression During Cell Cycle Progression and in the Maintenance of Genomic Stability , 2004, Cell cycle.
[120] N. Hanada,et al. E2f1 Mutation Induces Early Onset of Diabetes and Sjögren’s Syndrome in Nonobese Diabetic Mice1 , 2004, The Journal of Immunology.